BALDWIN BROTHERS LLC/MA - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 221 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALDWIN BROTHERS LLC/MA ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$12,000
+20.0%
2,5000.0%0.00%
+100.0%
Q2 2022$10,000
-33.3%
2,5000.0%0.00%
-50.0%
Q1 2022$15,000
-21.1%
2,5000.0%0.00%0.0%
Q4 2021$19,000
-17.4%
2,5000.0%0.00%
-33.3%
Q3 2021$23,000
-23.3%
2,5000.0%0.00%0.0%
Q2 2021$30,000
-3.2%
2,5000.0%0.00%
-25.0%
Q1 2021$31,000
-20.5%
2,5000.0%0.00%
-20.0%
Q4 2020$39,000
+62.5%
2,5000.0%0.01%
+66.7%
Q3 2020$24,000
+9.1%
2,5000.0%0.00%0.0%
Q2 2020$22,000
+37.5%
2,5000.0%0.00%0.0%
Q1 2020$16,000
-23.8%
2,5000.0%0.00%0.0%
Q4 2019$21,000
+50.0%
2,500
+66.7%
0.00%
+50.0%
Q3 2019$14,000
-12.5%
1,5000.0%0.00%0.0%
Q2 2019$16,000
+14.3%
1,5000.0%0.00%0.0%
Q1 2019$14,000
-17.6%
1,5000.0%0.00%
-33.3%
Q4 2018$17,000
-32.0%
1,5000.0%0.00%
-25.0%
Q3 2018$25,000
+19.0%
1,5000.0%0.00%
+33.3%
Q2 2018$21,000
-27.6%
1,5000.0%0.00%
-40.0%
Q1 2018$29,000
+16.0%
1,5000.0%0.01%
+25.0%
Q4 2017$25,000
+8.7%
1,5000.0%0.00%0.0%
Q3 2017$23,000
+76.9%
1,5000.0%0.00%
+100.0%
Q2 2017$13,000
+62.5%
1,5000.0%0.00%
+100.0%
Q1 2017$8,000
+60.0%
1,5000.0%0.00%0.0%
Q4 2016$5,000
-28.6%
1,5000.0%0.00%0.0%
Q3 2016$7,000
-22.2%
1,5000.0%0.00%
-50.0%
Q2 2016$9,0000.0%1,5000.0%0.00%0.0%
Q1 2016$9,0001,5000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders